Insulin Dosing in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis

Completed

Conditions studied: Diabetes, Hypoglycemia, Renal Dysfunction, Insulin Dosing

In brief

The purpose of this study is to assess whether the current recommendation for a 50% dose reduction in insulin for diabetic patients with a creatinine clearance (CrCl) ≤15 mL/min or on hemodialysis results in an increased number of hypoglycemic episodes.

Key facts

Study ID

NCT02083133

Run by

Cook County Health

People needed

496

Starts

2013-10-01

Expected to finish

2017-05-17

Last updated by the study team

2023-06-22

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Inpatient men and women 18 years of age and older with a diagnosis of type 2 diabetes mellitus (T2DM) with CrCl ≥60, 16-59 or ≤15 milliliters/minute.

You may not qualify if…

• Patients less than 18 years of age, pregnant patients

Where it is running

• John H Stroger Hospital of Cook County — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.